Reicin Alise
REICIN ALISE, CEO, reported a transaction classified as exercise at Tectonic Therapeutic, Inc. involving 10000.000000 shares for an estimated $23800.00. Reported holdings after the transaction were 319078.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Oct 26, 2026
- Filing date
- Oct 28, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
TECX price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001757533-26-000018 Common Stock
- Transaction date
- Oct 26, 2026 Filed Oct 28, 2026, 08:30 PM · 2d delay
- Shares
- 10,000 sh $2.38 per share
- Estimated value
- $23.8k Computed from shares × price
- Holdings after
- 319,078 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+10 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Executive Officer
- F1
These shares are held by the Reicin-Boiarsky Family Trust (the "Trust"). The Reporting Person's spouse is a co-trustee of the Trust. Accordingly, the Reporting Person may be deemed to have shared voti…
- F2
The shares subject to the option vested as follows: (i) 4,079 shares on June 30, 2024; (ii) 4,078 shares on July 31, 2024, (iii) 4,078 shares on August 31, 2024, (iv) 4,079 shares on September 30, 202…
- F3
Received in exchange for a stock option to acquire 63,478 shares of common stock pursuant to that certain merger, as more fully described on the Reporting Person's Form 4 filed with the Securities and…
0 other transactions
0 recent txs